Details for Patent: 9,200,002

Which drugs does patent 9,200,002 protect, and when does it expire?

Patent 9,200,002 protects AYVAKIT and is included in one NDA.

This patent has forty-seven patent family members in thirty-one countries.

Summary for Patent: 9,200,002

Title:	Compositions useful for treating disorders related to KIT
Abstract:	Compounds and compositions useful for treating disorders related to mutant KIT are described herein.
Inventor(s):	Hodous; Brian L. (Cambridge, MA), Kim; Joseph L. (Wayland, MA), Wilson; Kevin J. (Boston, MA), Wilson; Douglas (Ayer, MA), Zhang; Yulian (Acton, MA)
Assignee:	BLUEPRINT MEDICINES CORPORATION (Cambridge, MA)
Application Number:	14/515,327
Patent Claim Types: see list of patent claims	Use; Composition; Compound;

Understanding the Scope and Claims of a US Patent: A Detailed Analysis of US Patent 9,200,002

Introduction

When navigating the complex world of patents, understanding the scope and claims of a particular patent is crucial for inventors, businesses, and legal professionals. This article will delve into the specifics of US Patent 9,200,002, providing a comprehensive analysis of its scope, claims, and the broader patent landscape.

What is a Patent?

Before diving into the specifics of US Patent 9,200,002, it's essential to understand what a patent is. A patent is a form of intellectual property that grants the owner the exclusive right to make, use, sell, and distribute an invention for a certain period, usually 20 years from the filing date of the patent application[4].

The Importance of Patent Scope and Claims

The scope and claims of a patent define the boundaries of the invention and what is protected. The claims are the most critical part of a patent, as they specify the exact nature of the invention and what is considered novel and non-obvious[3].

US Patent 9,200,002: An Overview

To analyze US Patent 9,200,002, we need to look at its title, abstract, and most importantly, its claims.

Title and Abstract

While the specific details of US Patent 9,200,002 are not provided in the sources, a typical analysis would start with the title and abstract. These sections give a general idea of what the invention is about and its main features.

Claims

The claims section is where the patent's scope is defined. Here, you will find detailed descriptions of what the invention includes and what is protected. For example:

• Independent Claims: These claims stand alone and define the invention without reference to other claims.
• Dependent Claims: These claims refer back to and further limit the independent claims, often adding additional features or specifics.

Analyzing the Scope of US Patent 9,200,002

Claim Construction

Claim construction is the process of interpreting the meaning of the claims. This involves understanding the language used, the context in which it is used, and any definitions provided in the specification. The scope of the patent is determined by how broadly or narrowly these claims are interpreted[3].

Patent Scope Measurements

The USPTO has developed datasets and tools to measure patent scope, such as the Patent Claims Research Dataset. This dataset provides detailed information on claims from US patents and applications, including claim-level statistics and document-level statistics. These tools help in understanding the breadth and depth of the patent's protection[3].

Understanding Continuations and Their Impact

In the context of US patents, continuations can significantly affect the scope and claims. Continuations are new applications that are closely related to the original (progenitor) application and can include new subject matter or separate inventions. These continuations can lead to multiple patents from a single original application, complicating the calculation of allowance rates and the overall patent landscape[1].

The Broader Patent Landscape

Patent Allowance Rates

The probability of receiving a US patent is influenced by various factors, including the type of entity filing the application (large or small), the technology field, and the origin of the application (U.S. or foreign). The USPTO calculates different allowance rates, such as the first-action allowance rate, progenitor allowance rate, and family allowance rate, to provide a comprehensive view of the patent examination process[1].

Small Claims Patent Court

The concept of a small claims patent court has been explored to address issues related to the cost and complexity of patent litigation. This could potentially impact the patent landscape by providing a more accessible and cost-effective way for smaller entities to enforce their patent rights[2].

Tools and Resources for Patent Analysis

Patent Public Search

The USPTO offers several tools for searching and analyzing patents, including the Patent Public Search tool, which replaced older search tools like PubEast and PubWest. This tool provides enhanced access to prior art and improves the overall patent searching process[4].

Global Dossier

The Global Dossier service allows users to access the file histories of related applications from participating IP Offices, providing a comprehensive view of the patent family and related applications[4].

Common Citation Document (CCD)

The CCD application consolidates prior art cited by participating offices, enabling users to visualize search results for the same invention on a single page. This is part of the ongoing process of technical harmonization aimed at integrating the global patent system[4].

Key Takeaways

• Claims Define Scope: The claims section of a patent is crucial for understanding what is protected and the scope of the invention.
• Continuations Impact: Continuations can lead to multiple patents from a single original application, affecting the patent landscape.
• Patent Allowance Rates: Different allowance rates provide insights into the patent examination process and the likelihood of receiving a patent.
• Tools and Resources: The USPTO offers various tools and resources to aid in patent searching and analysis.
• Global Integration: Efforts like the Global Dossier and CCD aim to integrate the global patent system, making it easier to navigate and analyze patents internationally.

FAQs

Q: What is the primary purpose of the claims section in a patent? A: The primary purpose of the claims section is to define the scope of the invention and specify what is protected.

Q: How do continuations affect the patent landscape? A: Continuations can lead to multiple patents from a single original application, complicating the calculation of allowance rates and expanding the scope of protection.

Q: What is the Global Dossier service? A: The Global Dossier service provides access to the file histories of related applications from participating IP Offices, allowing users to view the patent family and related applications in one place.

Q: Why is claim construction important? A: Claim construction is important because it determines the meaning of the claims and thus the scope of the patent's protection.

Q: What tools does the USPTO offer for patent searching and analysis? A: The USPTO offers tools such as the Patent Public Search, Global Dossier, and Common Citation Document (CCD) to aid in patent searching and analysis.

Sources

1. Carley, M., & Hegde, D. (n.d.). What Is the Probability of Receiving a US Patent? YJOLT.
2. Administrative Conference of the United States. (n.d.). U.S. Patent Small Claims Court. ACUS.
3. United States Patent and Trademark Office. (2017, August 28). Patent Claims Research Dataset. USPTO.
4. United States Patent and Trademark Office. (2018, October 18). Search for patents. USPTO.

Drugs Protected by US Patent 9,200,002

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Blueprint Medicines	AYVAKIT	avapritinib	TABLET;ORAL	212608-004	Jun 16, 2021		RX	Yes	No	9,200,002		Y	Y		TREATMENT OF ADVANCED SYSTEMIC MASTOCYTOSIS, INCLUDING PATIENTS WITH AGGRESSIVE SYSTEMIC MASTOCYTOSIS (ASM), SYSTEMIC MASTOCYTOSIS WITH AN ASSOCIATED HEMATOLOGICAL NEOPLASM (SM-AHN), AND MAST CELL LEUKEMIA (MCL)
Blueprint Medicines	AYVAKIT	avapritinib	TABLET;ORAL	212608-004	Jun 16, 2021		RX	Yes	No	9,200,002		Y	Y		TREATMENT OF INDOLENT SYSTEMIC MASTOCYTOSIS (ISM)
Blueprint Medicines	AYVAKIT	avapritinib	TABLET;ORAL	212608-005	Jun 16, 2021		RX	Yes	No	9,200,002		Y	Y		TREATMENT OF ADVANCED SYSTEMIC MASTOCYTOSIS, INCLUDING PATIENTS WITH AGGRESSIVE SYSTEMIC MASTOCYTOSIS (ASM), SYSTEMIC MASTOCYTOSIS WITH AN ASSOCIATED HEMATOLOGICAL NEOPLASM (SM-AHN), AND MAST CELL LEUKEMIA (MCL)
Blueprint Medicines	AYVAKIT	avapritinib	TABLET;ORAL	212608-001	Jan 9, 2020		RX	Yes	No	9,200,002		Y	Y		TREATMENT OF UNRESECTABLE OR METASTATIC GASTROINTESTINAL STROMAL TUMOR (GIST) HARBORING A PLATELET-DERIVED GROWTH FACTOR RECEPTOR ALPHA (PDGFRA) EXON 18 MUTATION

International Family Members for US Patent 9,200,002

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
European Patent Office	3057969		301094	Netherlands
European Patent Office	3057969		PA2021003	Lithuania
European Patent Office	3057969		LUC00199	Luxembourg
European Patent Office	3057969		122021000014	Germany